Welcome to DukeHealth.org.
Skip over navigation
Skip over navigation
- Home
- Patient and Visitor Info
- Physicians
- Services
- Clinical Trials
- Event Calendar
- Locations
- Health Library
- About Duke Medicine
Quick Links
Duke Clinical Trial Leads to FDA Approval of First Cancer Vaccine
Share
Note: There is multimedia content on this page which requires the Flash viewer.
To see it, download and install the Flash plugin here:
Macromedia Flash Player
The Food and Drug Administration has approved the first ever cancer vaccine.
The immunotherapy, called Provenge, trains the immune system to attack prostate cancer cells.
In clinical trials at Duke University Medical Center, the vaccine extended the lives of patients who received it, by four months, on average.
1:35 (mm:ss)
